Affini-T
Tamyra Toole is a seasoned professional in regulatory affairs and quality assurance with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Senior Vice President at Affini-T Therapeutics since May 2023, Tamyra previously held roles including Senior Vice President and Vice President of Regulatory Affairs at Rubius Therapeutics from June 2018 to December 2022. Tamyra has also worked as a Regulatory Affairs Consultant from June 2017 to June 2018 and held significant positions at Infinity Pharmaceuticals, NitroMed, Wyeth Pharmaceuticals, and Millennium Pharmaceuticals. Tamyra holds a Doctor of Law (J.D.) degree from The Catholic University of America, Columbus School of Law, and a Bachelor of Science (BS) in Nursing from Villanova University.
This person is not in any teams
Affini-T
Affini-T is unlocking the power of T cells and targeting core oncogenic drivers to develop potentially curative therapies for solid tumor cancers.